Back to Top Skip to main content Skip to sub-navigation
In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge.

In December 2021, the FDA issued an Emergency Use Authorization (EUA) for two oral antivirals for the treatment of COVID-19: Paxlovid and Molnupiravir. TRICARE now covers these treatments at military pharmacies, in-network pharmacies, and non-network pharmacies, and beneficiaries will have a $0 charge. Share this image on your social media platforms to spread the news.

Recommended Content:

COVID-19 Treatment

What's New

Refine your search
Last Updated: February 23, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.